Acorda Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Acorda Therapeutics

09/11/2021 22:03

* Acorda Therapeutics Inc  ACOR.OQ  reported a quarterly
adjusted loss of $1.43​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of $1.56 per share.
* Revenue fell 40.7% to $31.46 million from a year ago; 
analysts expected $30.57 million. 
* Acorda Therapeutics Inc's reported EPS for the quarter was a
loss of $2.43​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Acorda Therapeutics Inc shares had fallen by 18.7% this
quarter and lost 9.7% so far this year.
* The company reported a quarterly loss of $27.07 million.
* Wall Street's median 12-month price target for Acorda
Therapeutics Inc is $10.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 10:03 p.m.
 ​All figures in US dollars unless otherwise stated